Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic or Locally Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07003815
What this trial is testing

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerAdvanced Cancer
Tongji Hospital 62
Early research (Phase 1)Study completedNCT01471847
What this trial is testing

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

Who this might be right for
Locally Advance Breast Cancer (LABC)Metastatic Breast Cancer (MBC)
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Testing effectiveness (Phase 2)Study completedNCT01372384
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05382299
What this trial is testing

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerPD-L1 Negative
Gilead Sciences 623
Large-scale testing (Phase 3)Study completedNCT02591030
What this trial is testing

Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours

Who this might be right for
Bile Duct Cancer
Centre Hospitalier Universitaire de Saint Etienne 191
Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing

HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.
Testing effectiveness (Phase 2)Study completedNCT02236195
What this trial is testing

Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

Who this might be right for
Urothelial Carcinoma
Mirati Therapeutics Inc. 17
Not applicableLooking for participantsNCT06657157
What this trial is testing

Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Cancer
Comprehensive Cancer Center Munich (CCCM) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562311
What this trial is testing

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder Cancer Stage IV
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Study completedNCT00006081
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00722072
What this trial is testing

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
OHSU Knight Cancer Institute 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623707
What this trial is testing

FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
FutureGen Biopharmaceutical (Beijing) Co., Ltd 264
Testing effectiveness (Phase 2)Study completedNCT00034177
What this trial is testing

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Who this might be right for
Urologic Neoplasms
Achieve Life Sciences 27
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Large-scale testing (Phase 3)WithdrawnNCT00403182
What this trial is testing

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Technical University of Munich
Large-scale testing (Phase 3)Study completedNCT02625623
What this trial is testing

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Who this might be right for
Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaGastric Cancer Third Line
EMD Serono Research & Development Institute, Inc. 371
Next Page